Ertapenem-Induced Encephalopathy in a Patient With Normal Renal Function
Author(s) -
S. Scott Sutton,
Mark Jumper,
Sean Cook,
Babatunde Edun,
Michael D. Wyatt
Publication year - 2017
Publication title -
journal of investigative medicine high impact case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.247
H-Index - 10
ISSN - 2324-7096
DOI - 10.1177/2324709616689376
Subject(s) - ertapenem , medicine , neurotoxicity , encephalopathy , discontinuation , renal function , adverse effect , adverse drug reaction , intensive care medicine , meropenem , drug , pharmacology , antibiotics , toxicity , antibiotic resistance , microbiology and biotechnology , biology
Drug-induced neurotoxicity is a rare adverse reaction associated with ertapenem. Encephalopathy is a type of neurotoxicity that is defined as a diffuse disease of the brain that alters brain function or structure. We report a patient with normal renal function who developed ertapenem-induced encephalopathy manifesting as altered mental status, hallucinations, and dystonic symptoms. The patient’s symptoms improved dramatically following ertapenem discontinuation, consistent with case reports describing ertapenem neurotoxicity in renal dysfunction. Since clinical evidence strongly suggested ertapenem causality, we utilized the Naranjo Scale to estimate the probability of an adverse drug reaction to ertapenem. Our patient received a Naranjo Scale score of 7, suggesting a probable adverse drug reaction, with a reasonable temporal sequence to support our conclusion.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom